Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. [electronic resource]
Producer: 19940811Description: 1159-66 p. digitalISSN:- 0027-8874
- Adolescent
- Adult
- Child
- Combined Modality Therapy -- adverse effects
- Cyclophosphamide -- therapeutic use
- Female
- Humans
- Injections, Intravenous
- Interleukin-2 -- adverse effects
- Lymphocytes, Tumor-Infiltrating -- transplantation
- Male
- Melanoma -- secondary
- Middle Aged
- Treatment Outcome
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.